A foretaste for pediatric glioblastoma therapy: targeting the NF-kB pathway with DHMEQ.

Autor: Brassesco MS; Department of Biology, Faculty of Philosophy, Sciences and Letters at Ribeirão Preto, University of São Paulo, Av. Bandeirantes, 3900, Bairro Monte Alegre, CEP 14040-901, Ribeirão Preto, SP, Brazil. solbrassesco@usp.br., Roberto GM; Department of Biology, Faculty of Philosophy, Sciences and Letters at Ribeirão Preto, University of São Paulo, Av. Bandeirantes, 3900, Bairro Monte Alegre, CEP 14040-901, Ribeirão Preto, SP, Brazil., Delsin LE; Department of Biology, Faculty of Philosophy, Sciences and Letters at Ribeirão Preto, University of São Paulo, Av. Bandeirantes, 3900, Bairro Monte Alegre, CEP 14040-901, Ribeirão Preto, SP, Brazil., Baldissera GC; Regional Blood Center of Ribeirão Preto, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil., Medeiros M; Department of Cell Biology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil., Umezawa K; Department of Molecular Target Medicine, Aichi Medical University School of Medicine, Aichi, Japan., Tone LG; Department of Pediatrics, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.

Publikováno v: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery [Childs Nerv Syst] 2023 Jun; Vol. 39 (6), pp. 1519-1528. Date of Electronic Publication: 2023 Feb 18.

The multifaceted NF-kB: are there still prospects of its inhibition for clinical intervention in pediatric central nervous system tumors?

Autor: Medeiros, Mariana, Candido, Marina Ferreira, Valera, Elvis Terci, Brassesco, María Sol

Publikováno v: Cellular & Molecular Life Sciences; Sep2021, Vol. 78 Issue 17/18, p6161-6200, 40p